IIT researchers develop carbon nanomaterials to detect and destroy cancer cells

The nanosized carbon material that can serve as therapeutic and diagnostic agents for cancer have been extracted from the leaves of the rosy periwinkle plant.

Researchers at the Indian Institute of Technology (IIT), Roorkee, have developed fluorescent carbon nanodots for simultaneous detection and destruction of cancer cells.

The nanosized (10-9 metre) carbon material that can serve as therapeutic and diagnostic agents for cancer have been extracted from the leaves of the rosy periwinkle plant, said PTI.

"Such events of real-time image guided anticancer therapy by a single system open a new paradigm in the field of anticancer therapy. With these nanomaterials, we can identify the cancer cells and track them by an imaging system simultaneously as the cells themselves are being eradicated in a precise surgical strike," said P Gopinath who is leading the team.

Dr Gopinath's team has synthesised carbon nanodots by heating the leaves of Catharanthus roseus, commonly called rosy periwinkle and Vinca rosea, in a process called "hydrothermal reaction”, said NDTV.

"We are planning next stage animal studies for further evaluation of these nanomaterials in oncological applications, for both diagnostics and treatment," he added.

The research by IIT scholars has been supported by the Science and Engineering Research Board (SERB) and the Department of Biotechnology (DBT), Union Ministry of Science and Technology.

"The identification of cancer cells and their inhibition/destruction have been continuing challenges in the field of oncology and cancer drug research for many decades. In the past few years, nanotechnology has emerged as one of the most promising areas in cancer diagnostics and treatment and nanomaterials materials having dimensions in the nanometre (10-9 m) range are being increasingly studied as agents in molecular tumour imaging, molecular diagnosis and targeted therapy," said Gopinath.

Do you have an interesting story to share? Please write to us at [email protected].To stay updated with more positive news, please connect with us on Facebook and Twitter